Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F10 | P00742 | 20/20 | 0.61 |
| ▸ | PLG | P00747 | 1/20 | 0.60 |
| ▸ | PROC | P04070 | 1/20 | 0.60 |
| ▸ | F2 | P00734 | 7/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24322945 | 0.93 | F10 (0.63) | F10PLGPROCF2 | |
| SCHEMBL24322550 | 0.89 | F10 (0.59) | F10PLGPROCF2 | |
| SCHEMBL24322558 | 0.88 | F10 (0.62) | F10PLGPROCF2 | |
| SCHEMBL24324315 | 0.85 | F10 (0.67) | F10PLGPROCF2 | |
| SCHEMBL24322949 | 0.85 | F10 (0.67) | F10PLGPROCF2 | |
| SCHEMBL7413859 | 0.81 | F10 (0.56) | F10PLGPROCF2 | |
| SCHEMBL24323873 | 0.80 | F10 (0.58) | F10PLGPROCF2 | |
| SCHEMBL24322934 | 0.80 | F10 (0.58) | F10PLGPROCF2 | |
| SCHEMBL7425743 | 0.78 | F10 (0.56) | F10PLGPROCF2 | |
| SCHEMBL7421559 | 0.78 | F10 (0.56) | F10PLGPROCF2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220122691-A1 | HtrA Inhibitors and CagA Inhibitors and Use Thereof | Psomagen Inc. (US) | 2022-04-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220122691-A1 | HtrA Inhibitors and CagA Inhibitors and Use Thereof | HTRA1, GIPR, HPN | F10 1781/4885PLG 1769/4885PROC 3215/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.